Organophosphorus compounds
TARGETMOL CHEMICALS INC 1A-116 5MG
Also available in 1 mL, 1 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg and bulk. Please contact Fisher for quotes.1A-116 is a specific Rac1 inhibitor. Purity 98.43%
Medchemexpress LLC 1-(3,5-dimethylphenyl)-3-(2-(trifluoromethyl)phenyl)guanidine | 1430208-73-3 | MFCD31619254 | 99.7% | 307.31 | C16H16F3N3 | 100 MG
A small-molecule Rac1 inhibitor that prevents EGF-induced Rac1 activation and disrupts Rac1-P-Rex1 interaction. It induces apoptosis and inhibits cell proliferation, migration, and cell-cycle progression in a concentration-dependent manner, and has demonstrated antimetastatic activity in vivo. Supplied as a white to off-white solid, it is intended for research applications.
- Inhibits Rac1 activation and Rac1-P-Rex1 interaction.
- Induces apoptosis and inhibits cell proliferation, migration, and cell-cycle progression.
- Demonstrates antimetastatic activity in vivo.
- Supplied as a white to off-white solid and as a DMSO solution.
- High purity suitable for research applications.
- Compatible with in vitro and in vivo assays for Rac1 pathway studies.
Medchemexpress LLC hsa-miR-185-3p mimic 20nmol | 20nmol
hsa-miR-185-3p mimics are small chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity
Medchemexpress LLC hsa-miR-296-3p agomi 5nmol | 5nmol
hsa-miR-296-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand 2 phosphorothioates at the 5 end 4 phosphorothioates at the 3 end 3 end cholesterol group and full-length nucleotide 2 -methoxy modification They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies Compared with miRNA mimics they exhibits enhanced cellular uptake stability and regulatory activity in vivo
Medchemexpress LLC rno-miR-223-3p antag 5nmol | 5nmol
rno-miR-223-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs The miRNA antagomirs have 2 phosphorothioates at the 5 end 4 phosphorothioates at the 3 end 1 cholesterol group at the 3 end and full-length nucleotide 2 -methoxy modification The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes thereby inhibiting miRNAs from functioning Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors they exhibits enhanced cellular uptake stability and regulatory activity in vivo
Medchemexpress LLC EMU-116 | 2241724-59-2 | 98.5% | 405.58 | 50 MG
EMU-116 is an orally active CXCR4 antagonist that can be used in the study of cancer. It is provided in various pack sizes, including 50 mg. This compound is intended for research use only.
- Orally active CXCR4 antagonist
- Used in the study of cancer
- High purity compound
Medchemexpress LLC hsa-miR-140-3p mimic 5nmol | 5nmol
hsa-miR-140-3p mimics are small chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity
Medchemexpress LLC EMU-116 | 2241724-59-2 | 98.5% | 405.58 | 100 MG
EMU-116 is an orally active CXCR4 antagonist. It can be used in the study of cancer.
- Orally active CXCR4 antagonist.
- Used in the study of cancer.
Medchemexpress LLC Triethyl phosphonoacetate | 867-13-0 | MFCD00009177 | 99.8% | 224.19 g/mol | C8H17O5P | 100g
Carbethoxymethyldiethyl phosphonate is a biochemical reagent that can be used as a biological material or organic compound for life science related research
Apexbio Technology LLC LEP (116-130) (mouse) 258276-95-8 10mg
LEP 116-130 (mouse) is an amidated peptide fragment derived from mouse leptin It is designed to mimic leptin-like biological activities thereby contributing to the regulation of energy balance and appetite through hypothalamic signaling pathways LEP 116-130 (mouse) exerts its biological activity by engaging pathways associated with body weight homeostasis and food consumption Based on these pharmacological properties LEP 116-130 (mouse) holds research potential in the fields of obesity metabolism regulation and related signaling pathologies